0001610717-23-000215.txt : 20230721
0001610717-23-000215.hdr.sgml : 20230721
20230721173253
ACCESSION NUMBER: 0001610717-23-000215
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230719
FILED AS OF DATE: 20230721
DATE AS OF CHANGE: 20230721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saxonov Serge
CENTRAL INDEX KEY: 0001786720
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39035
FILM NUMBER: 231103390
MAIL ADDRESS:
STREET 1: 10X GENOMICS, INC.
STREET 2: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 10x Genomics, Inc.
CENTRAL INDEX KEY: 0001770787
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 455614458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: (925) 401-7300
MAIL ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: 10X Genomics, Inc.
DATE OF NAME CHANGE: 20190315
4
1
form4.xml
X0508
4
2023-07-19
0001770787
10x Genomics, Inc.
TXG
0001786720
Saxonov Serge
10X GENOMICS, INC.
6230 STONERIDGE MALL ROAD
PLEASANTON
CA
94588
true
true
Chief Executive Officer
true
Class A Common Stock
2023-07-19
4
M
0
20845
5.04
A
909850
D
Class A Common Stock
2023-07-19
4
S
0
40000
60.0272
D
869850
D
Class A Common Stock
27
I
See footnote
Class A Common Stock
870
I
See footnote
Class A Common Stock
183350
I
See footnote
Class A Common Stock
16320
I
See footnote
Stock Option (right to buy)
5.04
2023-07-19
4
M
0
20845
0
D
2028-11-02
Class A Common Stock
20845
32478
D
The transaction reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022.
This transaction was executed in multiple trades at prices ranging from $60.00 to $60.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
All of the shares subject to the option are fully vested and exercisable as of the date hereof.
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
2023-07-21